Skip to content
The Longevity Archive
CagriSema in all countries

Legal status · Canada

Is CagriSema legal in Canada?

InvestigationalMetabolicEvidence: Moderate

No. CagriSema is not approved for any medical use in Canada; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.

CagriSema in Canada at a glance

ClassificationInvestigational, not approved
Health Canada approval statusNot approved by Health Canada; investigational
Evidence levelModerate (research strength: Strong)
ReviewedSep 2026

Classification and note come from the CagriSema profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.

What this means

  • 01

    CagriSema is being studied in registered clinical trials but has not received Health Canada marketing approval in Canada.

  • 02

    Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.

  • 03

    Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.

What CagriSema is

A fixed combination of the amylin analogue cagrilintide and semaglutide that produced about 23% weight loss in Phase 3 and has been filed for FDA approval.

CagriSema is Novo Nordisk's once-weekly fixed-dose combination of cagrilintide, a long-acting amylin agonist, and semaglutide, a GLP-1 agonist. 0% for placebo in the NEJM treatment-policy analysis), ahead of semaglutide alone.

Mechanism: Simultaneously agonizes amylin receptors (satiety) and the GLP-1 receptor (appetite, insulin, gastric emptying) for additive weight loss.

Regulatory history: Investigational; NDA submitted to the FDA in December 2025 (REDEFINE 1 and 2); decision expected 2026

How Health Canada treats this kind of product

Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.

The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for CagriSema at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

CagriSema in other countries

Frequently asked questions

Is CagriSema legal in Canada?

No. CagriSema is not approved for any medical use in Canada; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.

Can I buy CagriSema in Canada?

No approved product exists to buy. In Canada CagriSema is classified as "Investigational, not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.

Is CagriSema Health Canada approved?

No. In Canada CagriSema is classified as "Investigational, not approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Investigational; NDA submitted to the FDA in December 2025 (REDEFINE 1 and 2); decision expected 2026. Evidence level: Moderate.

Related compounds in Canada

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for CagriSema live on its compound profile.

CagriSema profile

This page is general information about the regulatory status of CagriSema in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.